Clinical research lies at the heart of who we are. Baxter uses scientific evidence systematically, and transparently, to inform the development of new and state-of-the-art solutions for patients around the world. Here you can find various studies, white papers and articles concerning important topics across the wide range of therapy areas served by Baxter.
The Clinical Benefits of HDx Therapy for Chronic HD Patients
The Nephrology Dialysis Transplantation (NDT) Journal has published results of two clinical studies comparing with Theranova dialyzer with the latest generation of high-flux dialyzers.Read More
A Focus on Clinical Research
Comparative Effectiveness of Dialyzers: A Longitudinal, Propensity Score-Matched Study of Incident Hemodialysis Patients - Sibbel et al.
Results of the HepZero study comparing heparin-grafted membrane and standard care show that heparin-grafted dialyzer is safe and easy to use for heparin-free dialysis - Laville et al.
Biofeedback dialysis for hypotension and hypervolemia: a systematic review and meta-analysis - Nesrallah et al.
Health status and quality of life reported by incident patients after 1 year on haemodialysis or peritoneal dialysis - Kutner NG, et al.
Longitudinal membrane function in functionally anuric patients treated with APD: Data from EAPOS on the effects of glucose and icodextrin prescription - Davies SJ, et al.
Superiority of Icodextrin Compared with 4.25% Dextrose for Peritoneal Ultrafiltration - Finkelstein F, et al.
Clinical effects of a peritoneal dialysis regimen low in glucose in new peritoneal dialysis patients: a randomized crossover study. - le Poole CY, et al.
A 3-Year, Prospective, Randomized, Controlled Study on Amino Acid Dialysate in Patients on CAPD - Li FK, et al.